It heals the gut lining, which in turn calms the brain, while also acting directly on neural tissues to protect and repair them
Closing: The Clinical Bottom Line on NAD+ vs Sermorelin NAD+ and Sermorelin are not interchangeable therapies chasing the same outcome
because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
Frequently Asked Questions Common questions about peptide therapy, consultations, treatment planning, and what patients can expect at Onyx Medical Wellness
Xu H, Yang HJ, Rose GM, Li XM
